Skip to Content

Insulin Degludec

In the US, Insulin Degludec (insulin degludec systemic) is a member of the drug class insulin and is used to treat Diabetes Mellitus, Diabetes - Type 1 and Diabetes - Type 2.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10AD06,A10AE06

CAS registry number (Chemical Abstracts Service)

0844439-96-9

Chemical Formula

C274-H411-N65-O81-S6

Molecular Weight

6103

Therapeutic Category

Antidiabetic agent

Chemical Name

N⁶,B²⁹-[N²-(15-carboxypentadecanoyl)-L-Ý-glutamyl]-des-B30-L-treonine-insulin human (WHO)

Foreign Names

  • Insulinum degludecum (Latin)
  • Insulin degludec (German)
  • Insuline dégludec (French)
  • Insulina degludec (Spanish)

Generic Names

Brand Names

  • Ryzodeg (Insulin Degludec and Insulin Aspartat)
    Novo Nordisk, Switzerland; Novo Nordisk, Mexico; Novo Nordisk, Netherlands; Novo Nordisk, Poland; Novo Nordisk, Portugal; Novo Nordisk, United States
  • Tresiba
    Novo Nordisk, Austria; Novo Nordisk, Bosnia & Herzegowina; Novo Nordisk, Switzerland; Novo Nordisk, Denmark; Novo Nordisk, Spain; Novo Nordisk, Finland; Novo Nordisk, United Kingdom; Novo Nordisk, Greece; Novo Nordisk, Italy; Novo Nordisk, Japan; Novo Nordisk, Lebanon; Novo Nordisk, Mexico; Novo Nordisk, Netherlands; Novo Nordisk, Norway; Novo Nordisk, Poland; Novo Nordisk, Portugal; Novo Nordisk, Russian Federation; Novo Nordisk, Sweden; Novo Nordisk, Slovakia; Novo Nordisk, United States
  • Xultophy (Insulin Degludec and Liraglutide)
    Novo Nordisk, Switzerland; Novo Nordisk, Germany; Novo Nordisk, United Kingdom; Novo Nordisk, Poland

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide